Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
(NASDAQ: MNPR) Delayed: 71.84 +1.30 (1.84%)
Previous Close $70.54    52 Week High $ 
Open $72.00    52 Week Low $ 
Day High $73.99    P/E N/A 
Day Low $70.20    EPS $ 
Volume 135,924